Home
Conditions
Diabetes Mellitus, Type 1

Clinical trial condition

Diabetes Mellitus, Type 1

Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.

2,859 public trials 319 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 1 trial results

Completed

Neulasta in Type 1 Diabetes

NCT00662519

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Completed

A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes

NCT02230631

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations: Säo Paulo, Brazil

View Trial Details

Completed

Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

NCT01969747

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations: 1245.78.43001 Boehringer Ingelheim Investigational Site Graz, Austria

1245.78.49001 Boehringer Ingelheim Investigational Site Neuss, Germany

View Trial Details

Completed

Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi Dose Injection

NCT01941238

Conditions: Autoimmune Diseases, Behavior, Diabetes Mellitus, +11 more
Locations: National Guards Hospital Dammam, Saudi Arabia

View Trial Details

Completed

Liraglutide as add-on to Insulin in Type 1 Diabetes

NCT02092896

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +9 more
Locations: Dept. of Endocrinology, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark

View Trial Details

Completed

Exercise in Type 1 Diabetes Mellitus

NCT02075567

Conditions: Autoimmune Diseases, Behavior, Blood Glucose Decrease During and After Defined Individual Exercise in T1DM, +9 more
Locations: Not specified

View Trial Details

Completed

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

NCT00229658

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Montgomery, Alabama, United States

Research Site Tucson, Arizona, United States

Research Site Anaheim, California, United States

View all 107 locations

View Trial Details

Completed

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

NCT01281098

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus Type I, +9 more
Locations: Center for Clinical Trials - Aibili Coimbra, Portugal

View Trial Details

Completed

Impact of ELKa, the Toolset for Food Exchanges Calculation on Metabolic Control in Pediatric Diabetic Patients.

NCT02194517

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: Medical University of Warsaw Warsaw, Poland

View Trial Details

Completed

Roles of T Helper 1 Cytokines in Type 1 Diabetes

NCT02389335

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: Medeniyet University Goztepe Training and Research Hospital Istanbul, Turkey (Türkiye)

View Trial Details

Diabetes Mellitus, Type 1

Diabetes Mellitus, Type 1 trial results

Related conditions